Resistance in vitro to low-dose aspirin is associated with platelet PlA1(GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T kozak (GP Ibα) polymorphisms
- 17 September 2003
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 42 (6), 1115-1119
- https://doi.org/10.1016/s0735-1097(03)00921-5
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Platelet polymorphisms in thrombotic disordersTransfusion Clinique et Biologique, 2001
- Platelet-Active DrugsChest, 2001
- Platelet glycoprotein polymorphisms as risk factors for thrombosisCurrent Opinion in Hematology, 2000
- AspirinCirculation, 2000
- Platelet GP IIIa Pl A Polymorphisms Display Different Sensitivities to AgonistsCirculation, 2000
- Monitoring of Aspirin (ASA) Pharmacodynamics with the Platelet Function Analyzer PFA-100®Thrombosis and Haemostasis, 2000
- Human Platelet‐Specific Alloantigens: UpdateVox Sanguinis, 1998
- PlA2 polymorphism and efficacy of aspirinThe Lancet, 1998
- A Polymorphism of a Platelet Glycoprotein Receptor as an Inherited Risk Factor for Coronary ThrombosisNew England Journal of Medicine, 1996